ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698931; 2) Community: the network communities that were significantly associated with the response to NSC 698931; 3) Molecule: the relationships between components within communities and NSC 698931; 4) MDR: the compounds that were significantly associated with the NSC 698931.

NSC Compound Enrichment Correlation
NSC 656925 Null 0.0223138217461955 0.40882742
NSC 664403 Null 0.0223138217461955 0.25001973
NSC 669885 Null 0.0223138217461955 0.51516829
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.0223138217461955 0.24621056
NSC 681151 Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl] amino]-, 1-adamantyl ester 0.0223138217461955 0.40044396
NSC 684909 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 0.0223138217461955 0.15968912
NSC 685988 Dihydroartemisinyl ether, stereoisomer of NSC-685989 0.0223138217461955 0.51244237
NSC 687015 Null 0.0223138217461955 0.3660303
NSC 691520 Null 0.0223138217461955 0.35077265
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.0223138217461955 0.39093963
Total:202  Current:129    [First] [Prev] [Next] [Last]